Pre-Filled Syringes and Injectable Drug Devices 2021

Memo

Device design, regulatory and strategic pathways for parenteral drug delivery SMi is proud to present the 13th Annual Pre-Filled Syringes Conference in London on 13th and 14th January 2021.  The pre-filled syringes industry is growing at an exponential rate. With increasing demand for self-administration, a rise in biologics, large-volume delivery and the delayed EU MDR at the forefront of the field, SMi’s 13th annual event will bring you the key insights you need to grow and enhance your pre-filled syringes portfolio and discover what the future holds for the PFS and combination products industry. Topics of discussion will include the latest updates on the EU MDR and Article 117, advances in novel drug products and biologics, parenteral packaging for pre-filled syringes, innovations in device design and platforms for combination products, lifecycle management and much more… The two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more. As Europe’s first Pre-Filled Syringes Conference of 2021, this event is not to be missed. We look forward to welcoming you to the conference in January. BENEFITS OF ATTENDING: Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation Gain insights from notified body and competent authority representatives addressing key regulatory requirements Understand how to optimize your lifecycle management strategy for a commercially successful device Explore and benchmark against industry advances in device design through case studies and real-world examples View the full agenda and speaker line-up online: www.pre-filled-syringes.com/INICOPwl  Chairs for 2020: Bjørg Kaae Hunter, Department Manager, RA CMC & Device; RA NextGen Drug-Device, Novo Nordisk Alphons Fakler, Head Medical Device Risk Management, Novartis Featured speakers: Brian Holly, Head of Human Factors, Devices Centre of Excellence, Pfizer Daniel Latham, Head Device Development & LCM, Novartis Rene Holm, Head and Scientifi c Director, Drug Product Development, Liquids and Parenterals, Janssen Stefano Martini, Responsible for Special Programs, Medical Devices Development, Sanofi Sarah Tang, Regulatory Affairs Manager, Devices Division, MHRA Abha Raveau violette, Device Manager, AstraZeneca Vikas Jaitely, Director, Global Regulatory Affairs Transitional Medicine and Devices, Merck Julia Frese, Director, TÜV SÜD Clemens Günther, Director, Senior Expert Nonclinical Safety, Bayer Jonathan Sutch, Technical Specialist, BSI Additional Contact Info: T: +44 (0)20 7827 6088 E: This email address is being protected from spambots. You need JavaScript enabled to view it. Follow us:  @SMiPharm #PFSSMi